Boston Scientific announces positive coverage policy for Intracept procedure

Boston Scientific has revealed that Health Care Service Corporation (HCSC) will now provide coverage for the Intracept procedure. This development marks a significant step for the Intracept procedure, enhancing its accessibility for patients under HCSC's purview. The decision to include the Intracept procedure under its coverage indicates HCSC's recognition of its potential benefits in treating chronic low back pain. This positive policy change is expected to encourage broader acceptance and utilization of the procedure within the healthcare sector, potentially improving outcomes for patients suffering from refractory low back pain.\n\n